![\"Authors](\"http:\/\/jbstjournal.com\/wp-content\/uploads\/2014\/10\/Authors-Instructions.jpg\")
<\/a><\/p>\nJournal of Bone and Soft Tissue tumors (JBST) is an International Peer Reviewed Journal Publishing articles related to care and research in field of bone and soft tissue cancers.<\/p>\n
Bone and Soft tissue cancers is a rapidly developing area both in terms of diagnostic modalities and innovation in treatment protocols thus increasing the life as well as improving the quality of life. Although number of patients may be comparatively low but the impact of these diseases is quite great and we believe this area requires an independent journal to provide single platform to publish all research and development in this important area..<\/p>\n
JBST is First of its kind journal where a complete journal is dedicated to Bone and Soft Tissue tumors. The submission format is kept very simple and practical.<\/p>\n
Scope of the Journal<\/strong><\/p>\n JBST will focus to integrate knowledge from all resources and create a common wisdom pool. The focus of the journal will be clinical, medical and surgical aspects of orthopaedic oncology but will also extend to include Basic sciences, clinical trials, molecular biology; genetics, pathology; radiodiagnosis, interventional radiology, radiotherapy, biomechanics; biomaterials; nanotechnology; and also special prosthesis designs. This journal primarily aims to cater to clinicians, researchers and health-care providers whose focus is on the understanding and treatment of bone and soft tissue tumors<\/p>\n JBST will be an international peer review Journal with contributions from all across the globe.<\/p>\n What is different about JBST?<\/p>\n The entire format of the Journal will be one of \u2018Integration\u2019 with basic science, clinical trials, clinical research, case based discussion, evidence based medicine, expert opinion, Videos, keynote presentations and web resources, all aiming together to \u2018Translate\u2019 into betterment of care in Bone tumors. The submission format is kept very simple and practical and accepted articles will be in form of case reports, case series, original articles, technical notes and also metanalysis and systematic review of literature with complications or complicated cases in focus.<\/p>\n The Journal will include many focused and novel features including those listed below:<\/p>\n GUEST EDITORIALS, INTERVIEWS & EXPERT OPINIONS: These will be invited from eminent clinician\/researcher who have vast experience in field of bone tumors<\/p>\n CASE REPORT: A single case that highlights a particular complication along with treatment strategy and methods of management of a unique\/difficult\/complicated case<\/p>\n ORIGINAL ARTICLES: Original articles on any study focused on surgical or nonsurgical treatment modality of bone and soft tissue tumors<\/p>\n BASIC SCIENCE: Original and review articles from field of basic research in bone tumors including genetic studies, histopathogical developments and biomechanical studies<\/p>\n PHARMACOLOGICAL STUDIES: Especially clinical trials and articles related to innovative drug and medical management of bone and soft tissue tumors.<\/p>\n ALLIED SCIENCES: articles from allied branches like radiotherapy, radiodiagnostics, interventional radiology and rehabilitation sciences would also be accepted in JBST<\/p>\n TECHNICAL NOTES: Specific technical tricks and pearls or improvisations during surgery or conservative management of a patient can be published in a more pictorial form including videos and graphic diagrams<\/p>\n CASE IMAGE: Only a single image of a unique case can spark a full-fledged discussion on diagnosis and treatment of it. This section will aim to publish such images with detailed descriptions of the case<\/p>\n COMPLEX & COMPLICATED CASES: A primarily complex or complicated cases which is difficult to manage with multiple factors in clinical decision making. Management protocol with decision making flowchart will be included in this<\/p>\n CASE STUDY: The other spectrum to primary complex case is multiply operated case that now presents with unique decision making scenarios which are complex and need personalized thought process and management plan. Most focus will be on the rationale of management and ultimate result. Patient perspective will also form a part of every case study<\/p>\n LITERATURE REVIEW: In form of special review, metanalysis or systematic reviews focussed on one particular complications or complicated cases.<\/p>\n JOURNAL REVIEW: A review of articles related to orthopaedic complications that are published in last one month in other Journals<\/p>\n LETTER TO EDITOR: On any topic or article that is published in the journal. Readers can share their own similar cases as published in the Journal<\/p>\n ________________________________________<\/p>\n Contact JBST: Authors should submit their manuscripts online using the online electronic submission system \u2018Scripture\u2019 developed for this journal by IORG. Please Click Here if you are ready to Submit your article.<\/p>\n Article Charges: Since the Journal is Open access, the cost of publication is shared by the author and the Journal equally. For every submission that is accepted for publication, the article processing charges will be 5000 INR (for papers from India) and 150 USD (for foreign articles). Open access will allow us to make your article free to access and download by everyone and will invite better citation and wide outreach. The article processing charges are lowest in the world as here both author and journal share the charges for each article [other similar journals have article processing charges of USD 2000 for making one article open access]. There are no charges for submitting the manuscript or for peer review and decision on the manuscript. Authors will usually receive a decision on their manuscript within 8-12 weeks.<\/p>\n All manuscripts are to be submitted via the Journal submission software \u2018Scripture\u2019 on the website www.jbstjournal.com Any other query regarding article formatting for submission process can also be mailed to All manuscripts are to be submitted via the Journal submission software \u2018Scripture\u2019 on the website www.jbstjournal.com<\/a> Any other query regarding article formatting for submission process can also be mailed to editor.jbst@gmail.com<\/a><\/p>\n Authors who publish with this journal agree to the following terms”<\/p>\n 1. The author (s) allow the right to first publication of the article entitled to the Journal of Bone and Soft Tissue Tumors in the event the work is published.<\/p>\n 2.The\u00a0 author(s) warrant(s) that the article is original, is not under consideration by another journal, and has not been published previously. The authors accept responsibility for releasing this material.\u201d<\/p>\n 3.In case a paper has previously been presented or published as a poster in a national or international conference, the author(s) must make a full disclosure to the editor about it. Such papers are still eligible for publication in the journal provided the author(s) disclose this during their submission.<\/p>\n 4. The authors state that a valid informed consent is taken from all human subjects that are included in their articles<\/p>\n For all purposes, the copyright of the articles belongs to the authors.<\/p>\n All authors are expected to disclose any commercial affiliations as well as consultancies, stock ownership, or patent-licensing arrangements that could be considered to pose a conflict of interest regarding the submitted article. A conflict-of-interest statement will be forwarded to the corresponding author for signature upon acceptance of the manuscript. The signature of all authors is required. No article will be published until return of the completed form to the journal office.<\/p>\n Download Conflict of Interest form:\u00a0http:\/\/jbstjournal.com\/wp-content\/uploads\/2014\/12\/coi_disclosure.pdf<\/a><\/p>\n (Conflict of Interest form<\/span>\u2013 COI is a special document. we can’t open it on the browser. To make its use download it on the desktop, even though it shows ” Please wait….” error and then open it. )<\/strong><\/p>\n Conflict of Interest forms are according to Guidelines by International Committee of Medical Journal Editors and Each Authors details have to be filled separately and submitted with the manuscript. Plagiarism is not permitted and Journal will check every article for plagiarism using \u2018Plagtracker\u2019 and google search.<\/p>\n Manuscripts should be written in English. Authors whose native language is not English should seek the assistance of a colleague who is a native English speaker and familiar with the field of the work. Authors are advised to follow the recommendations in the \u201cUniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication\u201d proposed by the International Committee of Medical Journal Editors (www.icmje.org). Manuscripts must be typed double-spaced with wide margins on A4 paper. The manuscript parts should be in the following order, with each section beginning on a new page: title page, abstract, text, acknowledgments, references, tables, figure legends, and figures. Number all lines in a continuous manner and number all pages in the bottom right corner beginning with the title page. For reports on randomized control studies, authors should refer to the CONSORT statement (www.consort-statement.org). Standard abbreviations and SI units should be used. Define abbreviations at first appearance in the text, figure legends, and tables, and avoid their use in the title and abstract. Use generic names of drugs and chemicals.<\/p>\n JBST accepts following formats of articles<\/p>\n Description of various format is provided below<\/p>\n Perspective<\/strong>s \u2013 A clinical overview of a common topic with aim to share with reader the recent update and current state of affairs<\/p>\n Insights<\/strong> – Invited article from an Expert in the Field specially focusing on their area of Research or Interest<\/p>\n \u00a0Interviews<\/strong> \u2013 Academicians and Researchers across the world will get a chance to feature in our interview section and share their views<\/p>\n Master Class<\/strong> \u2013 In this feature we will invite a \u2018Master\u2019 to demonstrate videos or pictorial demonstrations of surgical techniques or concepts.<\/p>\n Innovations<\/strong>: An innovative concept or an Idea that provides a new perspective. This needs to send directly to editorial email and after editorial review it will be send for peer review. 1000 words article describing the new concept, implant, protocol or surgical modification should be accompanied with a note of how this will be clinically relevant.<\/p>\n Burning Questions:<\/strong> Opinion\/Counter opinions from experts or group of experts on selected topics<\/p>\n Original Articles<\/strong>: include case series, comparative trials, epidemiological studies and RCT\u2019s<\/p>\n Case Reports:<\/strong> Have been detailed below and all the remaining formats follow similar guidelines as case reports<\/p>\n Case Image:<\/strong> is description of a single Image which has an unique learning point<\/p>\n Technical Note and Video Technique:<\/strong> detailed description of a new technique or improvisation of an old technique<\/p>\n \u00a0Surgical Tips:<\/strong> Small surgical tips and pearls are invited for this section. Pictures are essential and video will be preferable<\/p>\n Case Study:<\/strong> This new format combines the level V evidence with Clinical Decision Making (CDM). It focuses on getting the thought process of the treating surgeon when dealing with a complex\/complicated case<\/p>\n \u00a0Case Approach:<\/strong> This is a new but invited only section. We will invite an expert to describe to his approach to a particular case scenario with literature and rationale behind the approach<\/p>\n Clinical Perspective:<\/strong> this special section will publish specific learning points or experiences which the authors can share with the readers. The only essential point is that this perspective should be clinically relevant and rationally acceptable. This need not be with details of management or follow up of the case. The idea is to provide a platform for publication of these important and clinically relevant learning points. A single page write up of less than 1000 words will be accepted.<\/p>\n \u00a0Letter to Editor:<\/strong> on articles in JBST. Letters should be typed double-spaced and limited to 1000 words. A copy of the letter will be sent to the previous article\u2019s author(s) to invite a response.<\/p>\n \u00a0Letter to Experts:<\/strong> JBST will soon be creating an Expert panel of surgeons. Readers of JBST can ask queries regarding complicated cases to our Experts. These queries will be answered by experts and the Orthopaedic Research Group will add literature review to this expert opinion and article will be peer reviewed and published in 15 days.<\/p>\n Photo-Article<\/strong>: Pictorial articles which will be an easy read with most important message highlight<\/p>\n Following files will be essential for submission of any kind of article<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cover letter<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Title page<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Blinded manuscript<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tables<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Figure<\/p>\n –\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Conflict of Interest form<\/p>\n The details of formatting these files are provided below.<\/p>\n Manuscripts submitted to JBST must be submitted in the format described below. Articles that do not meet the journal’s style will not be peer reviewed or considered for publication. All articles should be no more than 3500 words long with a maximum of 50 references and 10 figures. Manuscripts should also contain an abstract of up to 350 words. Article will only be accepted for peer review in the following format:<\/p>\n Cover Page<\/p>\n Title page<\/p>\n Abstract<\/p>\n Keywords<\/p>\n Introduction<\/p>\n Material and Methods<\/p>\n Results:<\/p>\n Complications:<\/p>\n Discussion:<\/p>\n Conclusions:<\/p>\n Clinical Relevance:<\/p>\n References:<\/p>\n Illustrations and figures:<\/p>\n Figure legends (if any):<\/p>\n Additional data files (if any):<\/p>\n List of abbreviations used (if any):<\/p>\n Conflict of interests: To be downloaded from the website and a signed copy scanned and submitted along with manuscript \u00a0\u00a0[Download Here ]\u00a0<\/a> Authors’ contributions:<\/p>\n Acknowledgements and Funding:<\/p>\n Manuscripts should be submitted in Microsoft Word Document format<\/p>\n Cover Letter:<\/strong> This is the official letter written to editors by the author, where they can inform the editorial board about significance of their study. They can also inform regarding special situations like shared data with another study or long term follow up of already published article. This also provides the chance to authors to interact directly with editorial board and put up any specific point for considerations like more number of authors, manuscript exceeding word count or figure count.<\/p>\n Title Page<\/strong><\/p>\n The title should be concise and informative to make electronic retrieval of the manuscript both effective and specific. Include important information such as the study design, i.e., clinical or basic, and in particular indicate if the study is a randomized control trial. A running title not exceeding 35 letters and spaces should be provided.<\/p>\n Example of Title Page<\/p>\n The first page of the manuscript should be a dedicated title page, including the title of the article. The title should include the study design, i.e. Case report. For example<\/p>\n Authors Names should appear in sequence that will be final, with superscript numbers mentioning authors affiliations<\/p>\n Author Name A1<\/sup>, Author Name B2<\/sup>, Author Name C3*<\/sup><\/p>\n Address: 1<\/sup> Full designation, degree and postal address of author A; 2<\/sup> Full designation, degree and postal address of author B; 3 <\/sup>Full designation, degree and postal address of author C<\/p>\n * Corresponding author should be indicated with an asterisk.<\/p>\n The full names, institutional addresses and email addresses for all authors must be included on the title page. No other information should be included on this page.<\/p>\n The page should contain the article title, the full names of the authors including only major qualification such as M.D. or Ph.D., and the complete postal address of the department and institution where the work was done. Designate one author as a correspondent and supply his or her complete postal address, telephone number, fax number, and e-mail address. If the name or address for offprint requests is different, this should be stated. Every person listed as an author should have materially participated in the design, execution, and analysis of the study and should verify the accuracy of the entire manuscript before its submission. No more than 6 authors can be included in the title page. Lesser contributors may be noted in an acknowledgment section at the end of the manuscript.<\/p>\n Authorship criteria are as per the ICMJE Guidelines<\/strong> and include Authorship credit should be based only on substantial contributions:<\/p>\n For an original article the number of contributors should not exceed six; for case reports, letter to the Editor and review articles, the number of contributors should not exceed four. A justification should be included, if the number of contributors exceeds these limits.<\/p>\n Only those who have done substantial work in a particular field can write a review article. A short summary of the work done in the field of review should accompany the manuscript.<\/p>\n Example to state Author’s Contributions<\/strong><\/p>\n We suggest the following kind of format (please use initials to refer to each author’s contribution):<\/p>\n \u201cFC analyzed and interpreted the patient data regarding the fracture disease and the stiffness.\u00a0 RH performed the histological examination of the callus, and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.\u201d<\/p>\n All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance or a department chair who provided only general support.<\/p>\n Author information should not be included in the main document. Authors should submit the title page, the main document, and the Pictures separately. To ensure blinding, authors should not include in the abstract or text the name or initials of the authors or the institution at which the study was performed. Refer to your own published work in the third person. Use \u201cIn the previous work of Author name et al.\u201d, not \u201cIn our previous work.\u201d The blinded manuscript should contain title, abstract, keywords, main article with references, tables and figure legends<\/p>\n Abstract:<\/strong> This should start on page 2 of the manuscript. The abstract must not exceed 350 words. Do\u00a0 not use abbreviations or references in the abstract. The structured abstract should consist of four paragraphs: Background (including the context and purpose of the research), Methods, Results, and Conclusions. The abstract should be typed on a separate page, and should not include abbreviations, footnotes, or references. Abstract should make clear how the paper adds to the Orthopaedic literature:<\/p>\n Keywords:<\/strong> Add 3 to 5 keywords at the end of abstract. MESH terms will be preferable<\/p>\n Blinded Manuscript:<\/strong> The length of the text and references should not exceed 15 pages of double-spaced type. The number of figures and tables together should not exceed 20. Do not repeat in the text all data that appear in the tables or illustrations; emphasize or summarize only important observations. A conclusion may be included in the summary paragraph of the Discussion only if it is not redundant.<\/p>\n The blinded manuscript should not contain names of author or their institute. References should be numbered in order of appearance and should be placed in square brackets [1]. Manuscript is usually, but not necessarily, divided into sections with the headings Introduction, Materials and Methods, Results, Discussion and Clinical Relevance. Long articles may need section subheadings to clarify their content.<\/p>\n Introduction<\/strong>: should explain the background of the case, including the disorder, usual presentation and progression and an explanation of the presentation if it is a new disease. If it is a case discussing an adverse drug interaction the introduction should give details of the drug’s common use and any previously reported side effects. It should also include a brief literature review.<\/p>\n Material & Methods<\/strong> should be sufficiently detailed to allow easy understanding and reproduction of the study. Details of study design, outcome measures, outcome assessors and statistical methods have to be provided here. Surgical technique should be described in details with photographs and videos [videos should be uploaded on you tube and link to be submitted to us]<\/p>\n Results:<\/strong> Keep results very succinct and to the point. Write all data in mean \u00b1 SD [Range] with appropriate standard units. Mention p values till third decimal points. Use tables to display the numerical data. Do not interpret the results in this section. Provide details of complication events and their individual follow ups<\/p>\n Discussion:<\/strong> should be elaborate and should focus on the main results of your study. Individual resuts\u00a0should be addressed separately and put in context with the current literature.<\/p>\n Clinical relevance: of the study should be mentioned in three or four sentences<\/p>\n If abbreviations are used in the text they should either be defined in the text where first used, or a list of abbreviations can be provided.<\/p>\n This section is compulsory. It should provide a statement to confirm that the patient has given their informed consent for the case report to be published. You do not need to send the form to us on submission, but we may request to see a copy at any stage (including after publication<\/p>\n\n
\nemail: editor.jbst@gmail.com
\nwebsite: www.jbstjournal.com<\/p>\n
\nInstructions for Authors<\/strong><\/h2>\n
Manuscript Submission<\/h3>\n
<\/h3>\n
Authors Agreement<\/h3>\n
Conflict-of-interest Statement<\/h3>\n
Article submission Charges: None<\/h4>\n
Article Publishing charges: 5000INR or 150$ (for international article). The publishing charges has to paid only on acceptance of the article]<\/h4>\n
\n<\/h4>\n
Instructions for Manuscript Preparation<\/h2>\n
SUBMISSION FORMATS<\/h3>\n
\n
\n
\n
\n(Conflict of Interest form<\/span>\u2013 COI is a special document. we can’t open it on the browser. To make its use download it on the desktop, even though it shows ” Please wait….” error and then open it. )<\/strong><\/p>\n
\n\n
Blinded Submission<\/h3>\n
ADDITIONAL DETAILS<\/h2>\n
Abbreviations (if any)<\/h3>\n
\u00a0Consent<\/h3>\n
\u00a0Conflict of interests<\/h3>\n